CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy.
Honing, Judith
CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. [electronic resource] - Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Oct 2015 - 152-8 p. digital
Publication Type: Evaluation Study; Journal Article
1879-0887
10.1016/j.radonc.2015.08.031 doi
Aged
Biomarkers, Tumor--metabolism
Chemoradiotherapy, Adjuvant--methods
Disease-Free Survival
Esophageal Neoplasms--diagnosis
Female
Hedgehog Proteins--metabolism
Humans
Hyaluronan Receptors--metabolism
Male
Middle Aged
Neoadjuvant Therapy--methods
Neoplasm Proteins--metabolism
Prognosis
Retrospective Studies
SOXB1 Transcription Factors--metabolism
Treatment Outcome
CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. [electronic resource] - Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Oct 2015 - 152-8 p. digital
Publication Type: Evaluation Study; Journal Article
1879-0887
10.1016/j.radonc.2015.08.031 doi
Aged
Biomarkers, Tumor--metabolism
Chemoradiotherapy, Adjuvant--methods
Disease-Free Survival
Esophageal Neoplasms--diagnosis
Female
Hedgehog Proteins--metabolism
Humans
Hyaluronan Receptors--metabolism
Male
Middle Aged
Neoadjuvant Therapy--methods
Neoplasm Proteins--metabolism
Prognosis
Retrospective Studies
SOXB1 Transcription Factors--metabolism
Treatment Outcome